These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 6114914

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE, Lorenzi M, Bier DM, Tsalikian E, Schneider V, Karam JH, Forsham PH.
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Increase by somatostatin of the arginine induced rise in blood glucose in untreated insulin requiring diabetics.
    Waldhäusl W, Bratusch-Marrain P, Nowotny P.
    Endokrinologie; 1979 Apr; 73(3):323-7. PubMed ID: 499100
    [Abstract] [Full Text] [Related]

  • 6. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus.
    Ward FR, Leblanc H, Yen SS.
    J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060
    [Abstract] [Full Text] [Related]

  • 7. The antidiabetic action of somatostatin-28 as assessed by the artificial endocrine pancreas: greater potency than somatostatin-14.
    Hadjidakis DI, Raptis SA, Raptis AE, Karaiskos C, Souvatzoglou A, Diamantopoulos EJ.
    Horm Metab Res; 1987 Nov; 19(11):574-8. PubMed ID: 2892770
    [Abstract] [Full Text] [Related]

  • 8. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S, Pemberton C, Hunt P, Cole D, Raudsepp S, Inder W.
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [Abstract] [Full Text] [Related]

  • 9. Pituitary and extrapituitary effects of somatostatin in normal man.
    Copinschi G, Leclercq-Meyer V, Virasoro E, L'Hermite M, Vanhaelst L, Golstein J, Leclercq R, Féry F, Robyn C.
    Horm Metab Res; 1976 May; 8(3):226-31. PubMed ID: 181309
    [Abstract] [Full Text] [Related]

  • 10. Circadian variation of insulin requirement in insulin dependent diabetes mellitus the relationship between circadian change in insulin demand and diurnal patterns of growth hormone, cortisol and glucagon during euglycemia.
    Trümper BG, Reschke K, Molling J.
    Horm Metab Res; 1995 Mar; 27(3):141-7. PubMed ID: 7607604
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of acutely infused pentagastrin and somatostatin on intestinal calcium absorption in humans.
    Scholz D, Schwille PO.
    Miner Electrolyte Metab; 1982 Feb; 7(2):76-85. PubMed ID: 6133213
    [Abstract] [Full Text] [Related]

  • 13. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
    Alvestrand A, Mujagic M, Wajngot A, Efendic S.
    Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Studies on posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus.
    Kollind M.
    Acta Med Scand Suppl; 1988 Apr; 727():1-56. PubMed ID: 2903616
    [Abstract] [Full Text] [Related]

  • 16. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients.
    Wajchenberg BL, Cesar FP, Leme CE, Borghi VC, Souza VC, Souza IT, Neto DG, Germek OA, Coy DH, Comaru-Schally AM.
    Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329
    [Abstract] [Full Text] [Related]

  • 17. Postprandial glycaemic effects of a long-acting somatostatin analogue (octreotide) in non-insulin dependent diabetes mellitus.
    Williams G, Füessl HS, Burrin JM, Chilvers E, Bloom SR.
    Horm Metab Res; 1988 Mar; 20(3):168-70. PubMed ID: 2898427
    [Abstract] [Full Text] [Related]

  • 18. Metabolic effects of somatostatin in maturity-onset diabetes.
    Tamborlane WV, Sherwin RS, Hendler R, Felig P.
    N Engl J Med; 1977 Jul 28; 297(4):181-3. PubMed ID: 876274
    [Abstract] [Full Text] [Related]

  • 19. Low-dose infusion of somatostatin in man--no effect upon intestinal calcium absorption but a fall in blood insulin.
    Rümenapf G, Hanisch E, Schwille PO.
    Exp Clin Endocrinol; 1986 Aug 28; 87(3):306-12. PubMed ID: 2877894
    [Abstract] [Full Text] [Related]

  • 20. Route of administration as a factor in the selectivity of hormone suppression of a somatostatin analog in rats.
    Lien EL, Garsky VM.
    Horm Metab Res; 1981 Dec 28; 13(12):675-8. PubMed ID: 6119282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.